Bleeding Risk of Therapeutic Unfractionated Heparin and Low Molecular Weight Heparin in Patients with Cirrhosis.
Katherine L SummersKyle A DavisSarah Anne NislyPublished in: Clinical drug investigation (2020)
Low molecular weight heparin may be a safer option in patients with cirrhosis treated for acute venous thromboembolism, but future studies should confirm these findings.